Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.
作者信息
Dixon M F
机构信息
Academic Unit of Pathology, University of Leeds, Leeds LS2 9JT, UK.
出版信息
Gut. 2001 Jul;49(1):2-4. doi: 10.1136/gut.49.1.2.
Abstract
摘要
相似文献
1
Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia.
Gut. 2001 Jul;49(1):2-4. doi: 10.1136/gut.49.1.2.
2
Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8. doi: 10.1093/jnci/92.23.1881.
3
Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis.
Radiol Oncol. 2024 Apr 21;58(2):186-195. doi: 10.2478/raon-2024-0028. eCollection 2024 Jun 1.
4
Gastric cancer prevention from the point of Helicobacter.
Turk J Gastroenterol. 2014 Aug;25(4):463-7. doi: 10.5152/tjg.2014.8112.
5
Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis.
Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56. doi: 10.1046/j.1365-2036.2002.01311.x.
6
Precancerous lesions in the stomach: from biology to clinical patient management.
Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):205-23. doi: 10.1016/j.bpg.2012.12.007.
7
Preventing cancer by disrupting progression of precancerous lesions.
J Natl Cancer Inst. 2000 Dec 6;92(23):1868-9. doi: 10.1093/jnci/92.23.1868.
8
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication - a prospective study for up to 10 years.
Aliment Pharmacol Ther. 2018 Feb;47(3):380-390. doi: 10.1111/apt.14424. Epub 2017 Nov 29.
9
Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Asian Pac J Cancer Prev. 2015;16(4):1571-4. doi: 10.7314/apjcp.2015.16.4.1571.
10
Gastric Intestinal Metaplasia: An Intermediate Precancerous Lesion in the Cascade of Gastric Carcinogenesis.
J Coll Physicians Surg Pak. 2017 Mar;27(3):166-172.
引用本文的文献
1
Use of folic acid supplementation to halt and even reverse the progression of gastric precancerous conditions: a meta-analysis.
BMC Gastroenterol. 2022 Aug 2;22(1):370. doi: 10.1186/s12876-022-02390-y.
2
Epithelial cell plasticity: breaking boundaries and changing landscapes.
EMBO Rep. 2021 Jul 5;22(7):e51921. doi: 10.15252/embr.202051921. Epub 2021 Jun 6.
3
Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice.
Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1591-1597. doi: 10.1007/s10096-019-03564-5. Epub 2019 Apr 17.
4
Biochemical pathway analysis of gastric atrophy.
Gastroenterol Hepatol Bed Bench. 2018 Spring;11(2):118-124.
5
Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus.
World J Gastroenterol. 2014 Aug 21;20(31):10969-83. doi: 10.3748/wjg.v20.i31.10969.
6
Intestinal metaplasia and the risk of gastric cancer in an immigrant asian population.
Clin Med Insights Gastroenterol. 2012 Aug 23;5:43-50. doi: 10.4137/CGast.S10070. eCollection 2012.
7
Helicobacter pylori eradication for gastric cancer prevention.
J Gastroenterol. 2007 Jan;42 Suppl 17:10-5. doi: 10.1007/s00535-006-1939-2.
8
Histological risk markers for non-cardia early gastric cancer. Pattern of mucin expression and gastric cancer.
Virchows Arch. 2006 Dec;449(6):652-9. doi: 10.1007/s00428-006-0300-8. Epub 2006 Oct 13.
9
Helicobacter pylori infection causes gastric cancer? A review of the epidemiological, meta-analytic, and experimental evidence.
World J Gastroenterol. 2006 May 21;12(19):2991-9. doi: 10.3748/wjg.v12.i19.2991.
10
Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.
World J Gastroenterol. 2005 Nov 7;11(41):6518-20. doi: 10.3748/wjg.v11.i41.6518.
本文引用的文献
1
Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy.
J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8. doi: 10.1093/jnci/92.23.1881.
2
Preventing cancer by disrupting progression of precancerous lesions.
J Natl Cancer Inst. 2000 Dec 6;92(23):1868-9. doi: 10.1093/jnci/92.23.1868.
3
Reversible drug-induced oxyntic atrophy in rats.
Gastroenterology. 2000 Jun;118(6):1080-93. doi: 10.1016/s0016-5085(00)70361-1.
4
Genetic and epigenetic alterations in carcinogenesis.
Mutat Res. 2000 Apr;462(2-3):235-46. doi: 10.1016/s1383-5742(00)00005-3.
5
Stem cells in epithelial tissues.
Science. 2000 Feb 25;287(5457):1431-3. doi: 10.1126/science.287.5457.1431.
6
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication.
Gut. 2000 Jan;46(1):20-6. doi: 10.1136/gut.46.1.20.
7
An 18-year follow-up study of chronic gastritis and Helicobacter pylori association of CagA positivity with development of atrophy and activity of gastritis.
Scand J Gastroenterol. 1999 Sep;34(9):864-9. doi: 10.1080/003655299750025318.
8
The mucous neck cell in the human gastric corpus: a distinctive, functional cell lineage.
J Pathol. 1999 Feb;187(3):331-7. doi: 10.1002/(SICI)1096-9896(199902)187:3<331::AID-PATH241>3.0.CO;2-S.
9
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma.
Lab Invest. 1999 Jun;79(6):639-46.
10
Significant improvement of atrophy after eradication therapy in atrophic body gastritis.
Pathol Res Pract. 1998;194(9):609-13. doi: 10.1016/S0344-0338(98)80095-2.
Zotero 插件